Ibrutinib Interactions
There are 504 drugs known to interact with ibrutinib, along with 8 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 198 are major, 300 are moderate, and 6 are minor.
- View all 504 medications that may interact with ibrutinib
- View ibrutinib alcohol/food interactions (3)
- View ibrutinib disease interactions (8)
Most frequently checked interactions
View interaction reports for ibrutinib and the medicines listed below.
- Activated Charcoal (charcoal)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Augmentin (amoxicillin / clavulanate)
- Azithromycin Dose Pack (azithromycin)
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- Claritin (loratadine)
- Crestor (rosuvastatin)
- D3 (cholecalciferol)
- Eliquis (apixaban)
- Flomax (tamsulosin)
- Flonase (fluticasone nasal)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Iodides (sodium iodide)
- Lexapro (escitalopram)
- Lomotil (atropine / diphenoxylate)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Rituxan (rituximab)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Ventolin HFA (albuterol)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
Ibrutinib alcohol/food interactions
There are 3 alcohol/food interactions with ibrutinib.
Ibrutinib disease interactions
There are 8 disease interactions with ibrutinib which include:
- arrhythmias
- bleeding
- cytopenia
- hepatic impairment
- hypertension
- infections
- renal impairment
- tumor lysis syndrome
Report options
More about ibrutinib
- ibrutinib consumer information
- Compare alternatives
- Reviews (87)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Kesimpta
Kesimpta is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Calquence
Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Acalabrutinib
Acalabrutinib (Calquence) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Venetoclax
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or ...
Cyclophosphamide
Cyclophosphamide is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, brain ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
